Contents

Search


bionic pancreas

Investigational, wearable, automated, bihormonal device Also see automated closed-loop insulin delivery Indications: - diabetes mellitus type 1 Procedure: - continuous glucose monitor - delivers glucagon & insulin, based on an adaptive algorithm Clinical significance: - better glycemic control than insulin pump - lowers mean plasma glucose & duration of hypoglycemia [2] Notes: - iLet bionic pancreas, an automated system that requires patients to input only body weight & broadly estimated carbohydrate content of upcoming meals (usual, more or less)

Related

automated closed-loop insulin delivery; automated insulin dosing controller; automated glycemic controller device; artificial pancreas

General

prosthesis pancreas

References

  1. Russell SJ et al Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes. N Engl J Med. June 15, 2014 PMID: 24931572 http://www.nejm.org/doi/full/10.1056/NEJMoa1314474
  2. El-Khatib FH et al. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: A multicentre randomised crossover trial. Lancet 2016 Dec 19; PMID: 28007348 - Murphy HR, Stewart ZA. Automated insulin delivery: What's new, needed, and next? Lancet 2016 Dec 19; PMID: 28007347
  3. Bionic Pancreas Research Group. Multicenter, randomized trial of a bionic pancreas in type 1 diabetes. N Engl J Med 2022 Sep 29; 387:1161. PMID: 36170500 https://www.nejm.org/doi/10.1056/NEJMoa2205225 - Sherr J. Seeking simpler solutions with diabetes technology. N Engl J Med 2022 Sep 29; 387:1228. PMID: 36170505 https://www.nejm.org/doi/10.1056/NEJMe2210686